CLINICAL_TRIALS trial_result · 2015-01-01

Clinical Trial Update: Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC [Phase 2]

Phase II trial of dasatinib in previously treated advanced non-small cell lung cancer was terminated, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Duke University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-01-01